Skip to main content
Download PDF

Effects of treatment with Astragalus Membranaceus on function of rat leydig cells

BMC Complementary and Alternative Medicine volume 15, Article number: 261 (2015) Cite this article

Abstract

Background

Astragalus membranaceus (AM) is a Chinese traditional herb which has been reported to have broad positive effects on many diseases, including hepatitis, heart disease, diabetes and skin disease. AM can promote cell proliferation, increase the activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx), and inhibit apoptosis by regulating the transcription of proto-oncogenes controlling cell death. While AM is included in some commercially available “testosterone boosting supplements”, studies directly testing ability of AM to modulate testosterone production are lacking. In the present study, we examined the effects of AM on Leydig cell function in vitro.

Methods

Rat Leydig cells were purified and treated with AM at different concentrations (0 μg/mL, 10 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/mL and 150 μg/mL) and cell counting-8 (CCK-8) assay, Enzyme-linked immunosorbent assay, quantitative real time PCR and analysis of activities of SOD and GPx were done respectively.

Results

Treatment with 100 μg/mL (P < 0.05) and 150 μg/mL AM (P < 0.01) significantly increased Leydig cell numbers. Treatment with AM (20 μg/mL, 50 μg/mL and 100 μg/mL) significantly increased testosterone production (P < 0.01). In addition, increased Leydig cell SOD and GPx activities were observed in response to 20 μg/mL and 50 μg/mL AM treatment (P < 0.01). Furthermore, expression of Bax mRNA was significantly decreased (P < 0.01), and the ratio of Bcl-2/Bax mRNA was significantly increased in response to 20 μg/mL AM in the culture medium (P < 0.05).

Conclusions

Results supported a beneficial effect of AM on multiple aspects of rat Leydig cell function in vitro including testosterone production.

Peer Review reports

Background

Astragalus membranaceus (AM), a well-known Chinese medicinal plant, has been widely used as a traditional prescription medicine for treatment of various diseases, including hepatitis [1], diabetic nephropathy [2, 3], cardiovascular disorders [4, 5] and skin diseases [6]. AM has various favorable pharmacological effects including anti-fibrotic [1, 7–9], anti-oxidant [10], anti-apoptotic [11], anti-inflammatory [12] and immune-enhancing properties [13]. AM inhibits apoptosis mainly by regulating the expression of Bax and Bcl-2, members of the B cell leukemia protein (Bcl)-2 family that controls the intrinsic apoptotic pathway [14]. A previous study has shown that glucose-induced podocyte apoptosis was inhibited by intravenous AM injection in vivo and AM treatment in vitro with effects linked to down regulation of Bax expression and up-regulation of Bcl-2 expression [15]. Collectively, these observations indicate that AM has therapeutic effects in the context of various types of disease.

Although numerous studies support potential medicinal value of AM, its effects on the reproductive system have not been well investigated. Limited studies have demonstrated effects of AM on the motility of human spermatozoa in vitro [16] and amelioration of reproductive toxicity induced by cyclophosphamide in male mice [17] and sperm abnormalities in cadmium-treated rats [18]. Hong et al. tested effects of 18 types of Chinese herbs on semen parameters and only AM aqueous extract showed a significant stimulatory effect on the motility of human spermatozoa [16].

Leydig cells are distributed in the loose connective tissue between the seminiferous tubules, accounting for 2 %-4 % of testicular cells. Their main physiological function is to produce testosterone. Adult Leydig cells secrete testosterone required for the onset and maintenance of spermatogenesis [19]. However, studies directly testing effects of AM on Leydig cells and ability of AM to modulate testosterone production are lacking.

In the present study, we examined the effects of AM injection on rat Leydig cells, which supported a stimulatory effect on multiple aspects of rat Leydig cell function in vitro.

Methods

Materials All materials were obtained from Huaxia Biotech (Beijing, China) unless stated otherwise.

Animals Healthy male rats (n = 3) with average weight of 280-300 grams at 50-60 days of age were obtained from the Central Animal Services, Fudan University. Animals were euthanized by CO2 inhalation followed by cervical dislocation. All animal procedures were performed with approval of the Fudan University institutional animal care and use committee and in conformity with the guidelines for the care and use of laboratory animals formulated by the Ministry and Science and Technology of China (The Ministry and Science and Technology of the People’s Republic of China, Beijing, China, 2006).

AM solution preparation AM injection was purchased from Wu Jing Hospital (Shanghai, China), and each was loaded 100 mL which was equivalent to 20 grams of raw herb. AM injection was diluted in dimethyl sulfoxide (DMSO) (Sigma, Shanghai, China) at 10 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/mL and 150 μg/mL respectively for cell culture.

Isolation and purification of rat Leydig cells Testes were excised sterilely from male rats (n = 3) following euthanasia and placed in PBS (pH 7.0-7.2). After washing 2 times with PBS, the testes were placed in DMEM. After removing the epididymis, fat and tunica albuginea, the testes were shredded into small pieces and transferred to a 50 mL centrifuge tube containing DMEM. Leydig cells were dispersed by pipetting followed by centrifugation at 800 rpm for 10 min at 4 °C. Pellet was resuspended in medium followed by centrifugation twice at 600 rpm and 4 °C for 2 min. Supernatant was collected and the cells were seeded into culture dishes for 12 h at 37 °C with 5 % CO2. Culture medium was then replaced and cells cultured for another 12 h with Leydig cell purity assessed as described below.

3β-hydroxysteroid dehydrogenase (3β-HSD) staining The purity of cells was determined by 3β-HSD staining. After above described 24 h culture, media was removed and cells were removed from culture dish and placed in suspension. The Leydig cell suspension was incubated for 1 h at 37 °C with 1 mg/mL NBT (nitroblue tetrazolium), 3 mg/mL NAD+ (Nicotinamide Adenine Dinucleotide), 2 mg/mL DHEA (dehydroepiandrosterone) and1.6 mg/mL nicotinamide in 0.1 M PBS (Phosphate Buffered Saline). Stained cells were washed with PBS once and fixed in 10 % formaldehyde - 50 % ethanol (v/v) for 30 min, after which the cells were sedimented and washed two times. A drop of resuspended cell suspension was placed on a glass microscope slide. After drying, the percent of positive cells with a distinct blue reaction product were observed under a microscope (Olympus, Hong Kong, China).

Culture of Leydig cells and AM treatment Purified Leydig cells were seeded in either 96-well culture plates (3 × 103 cells/well) or 24-well culture plates (2 × 104 cells/well) and cultured in 90 % DMEM plus 10 % FBS and 1 % Penicillin-Streptomycin solution at 37 °C and 5 % CO2. Treatments consisted of culture medium without (control group with equivalent DMSO instead of AM injection) or with different concentrations of AM injection (10 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/mL, 150 μg/mL). 48 h after treatment, the cells and/or culture medium were collected and used in various assays described below. All experiments were repeated 3 times using testes obtained from different rats on different days.

Cell proliferation assay Cell proliferation was detected using a CCK-8 (cell counting kit-8) assay kit according to the manufacturer’s instructions (Dojindo, Shanghai, China). After above described 48 h culture, the culture medium was collected and Leydig cells were washed two times with 0.1 M PBS. Then 10 μL of CCK-8 reagent was added to each well and incubated at 37 °C for 2 h. The WST–8 (2 - (2 - methoxy - 4 - (phenyl) - 3 - (4 - (phenyl) - 5 - (2, 4 - sulpho benzene) - 2 H - tetrazolium monosodium salt) in the reagent can be reduced to orange-yellow formazan by dehydrogenase, which is proportional to the number of viable cells. Absorbance at 450 nm was recorded using a microplate reader (Thermo Scientific, Shanghai, China). A standard curve was designed using Leydig cell suspension with different dilution rates to calculate the viable cell numbers in each sample.

Testosterone Enzyme-Linked Immunosorbent assay (ELISA) Concentrations of testosterone in culture medium were detected using a Rat Free testosterone ELISA kit following the manufacturer’s instructions (Zhongtianjingwei Science and Technology Co., LTD, Beijing, China). The ELISA plates were read with a microplate reader (Thermo Scientific, Shanghai, China) to record the optical densities and testosterone concentrations derived from standard curve.

Assays for SOD and GPx activities After removing the medium, Leydig cells were suspended in 10 mM PBS (pH 7.0-7.2, 100-200 μL/106 cells) and cells lysed via homogenization. The mixture was centrifuged at 4,000 rpm for 10 min at 4 °C and supernatants (20-100 μg protein per sample according to the reagent specification) used for measurement of activity of SOD and GPx using the Total Superoxide Dismutase Assay kit (Jiancheng Bioengineering Institute, Nanjing, China) with WST-8 and Cellular Glutathione Peroxidase Assay Kit respectively (Jiancheng Bioengineering Institute, Nanjing, China). The activity of SOD and GPx was adjusted according to the protein concentrations in different samples.

Quantitative real time PCR Total RNA was isolated from the Leydig cell lysates using the miRNeasy mini kit following the manufacturer’s protocol (Qiagen, Shanghai, China). The integrity and concentration of total RNA were measured by agarose gel electrophoresis and Nanodrop-1000 spectrophotometer (Gene Company Limited, Hongkong, China), respectively. Total RNA (500 ng/sample) was then converted to cDNA using the iScript cDNA synthesis kit following the manufacturer’s instructions (Thermo Scientific, Shanghai, China). cDNA was diluted using nuclease free water to a final volume of 40 μL.

Quantitative real time PCR (qRT-PCR) was performed using a 20 μL reaction volume containing 10 μL of SYBR® premix Ex Taq™ II(Ruian Biotech., Shanghai, China), 0.4 of ROX Reference Dye II, 0.8 μL each of forward and reverse primer, 2 μL of cDNA and 6 μL of nuclease free water. Reactions were run on a 7500 Real Time PCR system (Thermo Scientific, Beijing, China) for 45 cycles of 95 °C for 15s followed by 60 °C for 1 min. GAPDH gene was used as the endogenous control. Primers were designed using Primer 3 (http://primer3.ut.ee/). The primers were as follows: GAPDH, 5′- TGGGTGTGAACCACGAGA -3′ (forward) and 5′-GGCATGGACTGTGGTCATGA -3 (reverse); Bax, 5′- AGGATGCGTCCACCAAGAAGC -3′ (forward) and 5′-CGGAAGAAGACCTCTCGGGG-3′ (reverse); Bcl-2, 5′- GGAGCGTCAACAGGGAGATG-3′ (forward) and 5′- CAGCCAGGAGAAATCAAACAGA -3′ (reverse). The relative mRNA expression level of Bax and Bcl-2 was calculated using the comparative 2−ΔΔCT method [20]. Here, we chose 20 μg/mL AM as the treatment, because the results of preliminary test indicated that AM in concentration of 20 μg/mL can significantly improve the biological function of Leydig cells, and the concentration is more economical in a real application.

Statistical analysis All data were analyzed in one way ANOVA using SPSS computer software (IBM, USA). Effects of AM treatment (control versus 20 μg/mL AM) on Bcl-2 and Bax mRNA were analyzed by Student’s t-test. Means were separated using Tukey’s test. Data are presented as mean ± SE.

Results

Leydig cell purity To assess the purity of cultured Leydig cells, 3β-HSD staining was performed. The results showed that the purity of cultured Leydig cells was > 95 % (Fig. 1).

Fig. 1
figure1

3β-HSD staining of Leydig cells. a Magnification, 100×; b Magnification, 400×. LC, Leydig cell

Full size image

AM treatment increased Leydig cell numbers To investigate the effect of AM injection on Leydig cells, numbers of viable cells were determined by CCK-8 assay 48 h after AM treatment. Compared with the untreated control, numbers of viable cells increased within a certain range of concentration, particularly at the concentrations of 100 μg/mL (P < 0.05) and 150 μg/mL (P < 0.01) (Fig. 2). The result suggested that addition of AM increases numbers of viable Leydig cells 48 h after treatment.

Fig. 2
figure2

Effect of AM treatment on viable Leydig cell numbers. Cells were treated with 0 μg/mL, 10 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/mL and 150 μg/mL of AM. Cell viability was analyzed by CCK-8 assay. Results are depicted as mean +/- SE * P < 0.05, ** P < 0.01

Full size image

AM treatment increased Leydig cell testosterone production To determine potential effects of AM on the production of testosterone in Leydig cells, cells were treated with increasing concentrations of AM. Significantly higher concentrations (P < 0.01) of testosterone were observed in culture media of cells treated with 20 μg/mL, 50 μg/mL, and 100 μg/mL of AM injection for 48 h (compared with untreated control; Fig. 3), suggesting certain stimulatory effects of AM injection on Leydig cell testosterone production. Intra- assay and inter- assay coefficients of variation were < 11% and < 9 %, respectively.

Fig. 3
figure3

Effect of AM treatment on testosterone production in Leydig cells. Cells were treated with 0 μg/mL, 10 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/mL and 150 μg/mL of AM. Testosterone production in culture medium was determined by ELISA (enzyme-linked immuno sorbent assay). Results are depicted as mean +/- SE, * P < 0.05, ** P < 0.01

Full size image

AM injection treatment increased SOD and GPx activities To determine the effect of AM on the antioxidant defense system, the activities of SOD and GPx were detected in cultured Leydig cells 48 h after AM treatment. As shown in Fig. 4, the activities of SOD and GPx were significantly increased in Leydig cell cultures treated with 20 μg/mL and 50 μg/mL of AM relative to untreated controls (P < 0.01). Results indicated AM treatment could increase Leydig cell antioxidant activity within a certain range of concentration.

Fig. 4
figure4

Effect of AM treatment on the activities of SOD and GPx in Leydig cells. Cells were treated with 0 μg/mL, 10 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/mL and 150 μg/mL of AM. a SOD activity. b GPx activity. Results are depicted as mean +/- SE, * P < 0.05, ** P < 0.01

Full size image

Effect of AM on Bax and Bcl-2 mRNA expression in AM treated Leydig cells To further elucidate the potential effects of AM on Leydig cell numbers, the expression of apoptosis-related genes Bax and Bcl-2 in Leydig cells treated with 0 μg/mL or 20 μg/mL of AM injection for 48 h were analyzed using qRT-PCR. Results showed in Fig. 5 indicated the expression of Bax mRNA was significantly reduced in AM treated group (P < 0.01) compared with the untreated control, while the expression of Bcl-2 mRNA had no obvious change between AM treated group and the untreated control (P > 0.05). However, the ratio of Bcl-2/Bax mRNA was significantly higher in the AM treated group versus the untreated control (P < 0.05).

Fig. 5
figure5

Effect of AM treatment on the expression of Bax and Bcl-2 in Leydig cells. qRT-PCR was performed to determine the abundances of Bax (a) and Bcl-2 (b) mRNA in Leydig cells treated with 20 μg/mL of AM, and to further determine the effect of AM treatment on expression level of Bax and Bcl-2, we calculated the ratio of Bcl-2 to Bax (c). Expression of Bax and Bcl-2 mRNA was normalized relative to the abundance of GAPDH mRNA. Results are depicted as mean +/- SE (n = 3). * P < 0.05, ** P < 0.01

Full size image

Discussion

Many studies have suggested a positive role for AM in the treatment of various diseases. In the present study, we investigated the effect of AM injection on function of rat Leydig cells. According to the instructions for AM injection and relevant reference [21], we at first used AM concentrations that ranged from 0-80 μg/mL to take the preliminary test. The result showed that there was no significant difference in cell number among these concentrations (the result was not provided). After several times of preliminary test and adjusting the concentration gradient, finally we chose 0 μg/mL, 10 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/mL, 150 μg/mL as the test concentration gradient.

Several studies have reported stimulatory effects of Astragaloside (main compound extracted from AM) [4, 22] on cell proliferation, which was also observed in this study. Leydig cells influence sexual maturation of males by secreting testosterone, which is influenced by cell number and rate of steroidogenesis. However, significant changes in cell proliferation and testosterone production did not occur at the same dosage of AM. The increase in testosterone production occurred at lower concentrations of AM than those demonstrated to increase Leydig cell numbers. Results suggested direct effects of AM on regulation of steroidogenesis independent of modulation of cell numbers.

Apoptosis is regulated by various factors, among which pro- and anti-apoptotic proteins of Bcl-2 family play an important role. Relative to the absolute expression of either gene alone, the ratio of Bcl-2 to Bax is regarded as a better determinant to measure cell survival [23]. In the present study, we found significantly decreased Bax expression in the AM treated Leydig cells, which is consistent with a previous study demonstrating similar effects of AM on Bax expression in skin [11]. However, AM treatment did not increase Leydig cell Bcl-2 expression in the current studies. Therefore, the increased ratio of Bcl-2/Bax in AM treated group may be attributed to the inhibitory effect of AM on Bax mRNA. A previous study demonstrated that intravenous injection of Astragaloside down-regulated Bax mRNA to reduce apoptosis in a rodent acute kidney injury model [3].

SOD catalyzes the dismutation of the superoxide anion, and GPx mediates the breakdown of hydrogen peroxide. These enzymes, as well as other antioxidant enzymes, are the main components of antioxidant defense system that possesses high potency to scavenge reactive oxygen species free radicals that are detrimental to cell survival by affecting cellular signaling pathways and gene expression. In the present study, we detected increased activities of SOD and GPx in the AM treated Leydig cells, supporting the antioxidant role of AM. Previous studies linked the therapeutic effects of AM on myocardial ischemia [24], ischemic brain injury [25], hemorrhagic shock-reperfusion injury of intestinal mucosa [26] and the epithelial-to-mesenchymal transition in diabetic kidney disease [21] to increased activities of antioxidant enzymes such as GPx and SOD. A large body of evidence indicates antioxidants can suppress apoptosis. Hence, it is plausible that the increase in Leydig cell numbers is linked, at least in part, to stimulatory effects of AM on SOD and GPx activity resulting in reduced apoptotic cell death.

Cell proliferation is a process regulated by lots of factors. The SOD and GPx activity was just one aspect that could be considered to evaluate the growth of Leydig cells. Perhaps AM at the concentrations of 20 μg/mL and 50 μg/mL was optimal for the SOD and GPx activity of Leydig cells although it had no obvious promotion for cell proliferation. With the increase of concentration, the amount of AM was too much for the SOD and GPx, so the activity decreased, but the number of Leydig cells was significantly increased in the process. Perhaps all above lead to the result that the treated group in which there was a significant difference of Leydig cell number was not consistent with that of SOD and GPx activity. Results suggested direct effects of AM on regulation of SOD and GPx activity independent of modulation of cell numbers.

Although the study preliminarily indicated that AM injection has a stimulatory effect on multiple aspects of rat Leydig cell function in vitro, it had some limitations, such as the design of AM injection gradient, and this was just the results of cell culture level. Therefore, lots of work and study should be done to elucidate the exact mechanism of AM promoting the function of Leydig cells.

Conclusions

In the present study, we investigated the influence of AM injection on cell numbers and testosterone production of rat Leydig cells cultured in vitro. The results suggested that AM injection has a favorable effect on the function of Leydig cells. The study provides a foundation for future studies to understand the mechanisms responsible for stimulatory effects of AM injection on Leydig cells and whether AM treatment in vivo can enhance indices of male fertility.

References

  1. 1.

    Rato L, Alves MG, Socorro S, Duarte AI, Cavaco JE, Oliveira PF. Metabolic regulation is important for spermatogenesis. Nat Rev Urol. 2012;9:330–8.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Zhang YW, Wu CY, Cheng JT. Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-kappaB and IkappaB in renal cortex of streptozotoxin-induced diabetic rats. J Ethnopharmacol. 2007;114:387–92.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Gui D, Huang J, Guo Y, Chen J, Chen Y, Xiao W, et al. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-kappaB-mediated inflammatory genes expression. Cytokine. 2013;61:970–7.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Zhang Y, Hu G, Li S, Li ZH, Lam CO, Hong SJ, et al. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo. Mol Med Rep. 2012;5:805–11.

    CAS  PubMed  Google Scholar 

  5. 5.

    Zhang L, Liu Q, Lu L, Zhao X, Gao X, Wang Y. Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1alpha accumulation via phosphatidylinositol 3-kinase/Akt pathway. J Pharmacol Exp Ther. 2011;338:485–91.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Kim BH, Oh I, Kim JH, Jeon JE, Jeon B, Shin J, et al. Anti-inflammatory activity of compounds isolated from Astragalus sinicus L. in cytokine-induced keratinocytes and skin. Exp Mol Med. 2014;46:e87.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Gao J, Feng LJ, Huang Y, Li P, Xu DJ, Li J, et al. Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling. J Pharm Pharmacol. 2012;64:811–20.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Li Z, Zhang L, He W, Zhu C, Yang J, Sheng M. Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-beta1 (TGF-beta1) pathway in rats submitted to peritoneal dialysis. Int J Mol Sci. 2014;15:12959–71.

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Wei MG, Sun W, Xiong PH, Shao JD. Antifibrotic effect of the Chinese herbs Modified Danggui Buxue Decoction on adriamycin-induced nephropathy in rats. Chin J Integr Med. 2012;18:591–8.

    Article  PubMed  Google Scholar 

  10. 10.

    He Y, Du M, Gao Y, Liu H, Wang H, Wu X, et al. Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels. PLoS ONE. 2013;8:e76495.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Kim MH, Kim SH, Yang WM. Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling. PLoS ONE. 2014;9:e92984.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Wang B, Chen MZ. Astragaloside IV possesses antiarthritic effect by preventing interleukin 1beta-induced joint inflammation and cartilage damage. Arch Pharm Res. 2014;37:793–802.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Hong F, Xiao W, Ragupathi G, Lau CB, Leung PC, Yeung KS, et al. The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines. Planta Med. 2011;77:817–24.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Botchkareva NV, Ahluwalia G, Shander D. Apoptosis in the hair follicle. J Invest Dermatol. 2006;126:258–64.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Gui D, Guo Y, Wang F, Liu W, Chen J, Chen Y, et al. Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo. PLoS ONE. 2012;7:e39824.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Hong CY, Ku J, Wu P. Astragalus membranaceus stimulates human sperm motility in vitro. Am J Chin Med. 1992;20:289–94.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Kim W, Kim SH, Park SK, Chang MS. Astragalus membranaceus ameliorates reproductive toxicity induced by cyclophosphamide in male mice. Phytother Res. 2012;26:1418–21.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Liang P, Li H, Peng X, Xiao J, Liu J, Ye Z. [Effects of astragalus membranaceus injection on sperm abnormality in Cd-induced rats]. Zhonghua Nan Ke Xue. 2004;10:42–5. 48.

    PubMed  Google Scholar 

  19. 19.

    Chen H, Ge RS, Zirkin BR. Leydig cells: from stem cells to aging. Mol Cell Endocrinol. 2009;306:9–16.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Shi L, Zhao H, Ren Y, Yao X, Song R, Yue W. Effects of different levels of dietary selenium on the proliferation of spermatogonial stem cells and antioxidant status in testis of roosters. Anim Reprod Sci. 2014;149:266–72.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Qi W, Niu J, Qin Q, Qiao Z, Gu Y. Astragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells. Cell Stress Chaperones. 2014;19:105–14.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Junior AA, Oliveira LS, Assis Neto AC, Alves FR, Miglino MA, Carvalho MA. Spermatogenesis in goats with and without scrotum bipartition. Anim Reprod Sci. 2012;130:42–50.

    Article  PubMed  Google Scholar 

  23. 23.

    Tanaka K, Asanuma M, Ogawa N. Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells. Neurochem Res. 2004;29:1529–36.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Zhang WD, Chen H, Zhang C, Liu RH, Li HL, Chen HZ. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med. 2006;72:4–8.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu JH, et al. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett. 2004;363:218–23.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Hei ZQ, Huang HQ, Zhang JJ, Chen BX, Li XY. Protective effect of Astragalus membranaceus on intestinal mucosa reperfusion injury after hemorrhagic shock in rats. World J Gastroenterol. 2005;11:4986–91.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was Supported by Chinese Natural Science Foundation (No. 31172211), Shanxi Scholarship Council of China (2014-key 5), and Shanxi Talent Introduction Project and SXAU Research Achievement Development Project(71060003).

Author information

Author notes

    Affiliations

    1. College of Animal Science and Technology, Shanxi Agricultural University, No.1 Mingxian Nan Road, Taigu, 030801, China

      Xiaolong Jiang, Xia Cao, Yang Huang, Jianwei Chen, Xiaolei Yao, Miaomiao Zhao, Yan Liu, Jinzhu Meng, Jianbo Yao, George W Smith & Lihua Lv

    2. College of Life Science, Shanxi Agricultural University, Taigu, Shanxi, 030801, China

      Pengfei Li

    3. Pharmaceutical Analysis Laboratory of Fudan University, Shanghai, 200000, China

      Zhiyan Li

    4. Laboratory of Mammalian Reproductive Biology and Genomics, Michigan State University, East Lansing, MI, 48824, USA

      George W Smith

    5. Departments of Animal Science, Michigan State University, East Lansing, MI, 48824, USA

      George W Smith

    6. Departments of Animal Physiology, Michigan State University, East Lansing, MI, 48824, USA

      George W Smith

    7. Division of Animal and Nutritional Sciences, West Virginia University, Morgantown, WV, 26506, USA

      Jianbo Yao

    Authors
    1. Xiaolong Jiang
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Xia Cao
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Yang Huang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Jianwei Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Xiaolei Yao
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Miaomiao Zhao
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Yan Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Jinzhu Meng
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Pengfei Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Zhiyan Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Jianbo Yao
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. George W Smith
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. Lihua Lv
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Lihua Lv.

    Additional information

    Competing interests

    The authors declare that they have no competing interests.

    Authors’ contributions

    XLJ performed the statistical analyses and drafted the manuscript. XC participated in the design of the study and carried out the assays. XLY, JWC and MMZ assisted in the cell culture assays. YL and JZM assisted in the Quantitative real time PCR and ELSIA. ZYL participated in the design of the study and provided technical supports. YH and PFL participated in the statistical analyses and assisted in drafting the manuscript. JBY, GS and LHL provided conceptual advice and critically revised the manuscript. All authors read and approved the final manuscript.

    Xiaolong Jiang and Xia Cao contributed equally to this work.

    Rights and permissions

    Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

    The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

    To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

    The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Jiang, X., Cao, X., Huang, Y. et al. Effects of treatment with Astragalus Membranaceus on function of rat leydig cells. BMC Complement Altern Med 15, 261 (2015). https://doi.org/10.1186/s12906-015-0776-3

    Download citation

    Keywords

    • Astragalus membranaceus
    • Leydig cell
    • SOD and GPx
    • Bax
    • Bcl-2
    • Testosterone

    BMC Complementary Medicine and Therapies

    ISSN: 2662-7671

    Contact us

    \